Category Archives: leadership

Genentech Runs Voluntary Corrective Ads for Boniva

Even though Roche-owned Genentech wasn’t required to run costly corrective advertisements following an FDA Untitled Letter on Boniva last January, the company has done so anyway.
Also posted in Advertising, Corporate Responsibility, FDA, Legal, Marketing, Regulatory, compliance | Tagged , , , | Leave a comment

The Rising Clout of the Patient

by Sarah Krüg In 2011, the patient’s clout as a stakeholder was firmly established, as reflected in several industry conferences. What’s next for the patient in 2012?
Also posted in Events, Meetings, Patient Communication, Strategy, Technology, patient education, social media | Tagged , , | 1 Comment

Arise Sir Andrew (Witty)

Big Pharma received a nod in the UK’s New Year’s Honours List this week when a knighthood was duly bestowed upon GSK’s Andrew Witty — making him ‘Sir Andrew’ to you and me. For once, though, receiving such an honor did not exactly place him in totally exalted company.
Also posted in Global, Op-Ed | Tagged , , , | Leave a comment

Lilly's Decentralized Global Launch Strategy

Global headquarters may get the strategic ball rolling for a new drug launch, but Lilly’s affiliates are responsible for bringing home the bacon, according to a Lilly global brand director.
Also posted in Global, Market Access, Strategy | Tagged , | Leave a comment

What Pharma Could Do for Occupy Wall Street

Demonstrators at Zuccotti Park in New York City persevered through the first snow of the season, while reports from other U.S.-based occupations – in Denver, Oakland, Nashville and other cities – are tallying the arrests, which have become increasingly frequent, and forceful. “The whole world is watching,” a chant that gained prominence during anti-war protests [...]
Also posted in Corporate Responsibility, Events, Market Access, Strategy | Tagged , | 7 Comments